Agile Medical Technology

Agile Medical Technology (Suzhou) Co., Ltd. develops endoscopic surgical robot systems for minimally invasive procedures across multiple surgical specialties. The company’s AGIBOT platform received NMPA clearance in March 2025, positioning it among the growing cohort of domestic laparoscopic robot manufacturers in China.

Company Overview

Founded in September 2020, Agile Medical Technology is headquartered in Suzhou’s Wuzhong District. The founding team comprises experienced professionals from the surgical robotics industry with backgrounds spanning product development and commercial operations.

The company has assembled a multidisciplinary R&D team with expertise in mechanical engineering, optics, electronics, algorithms, and software development. This team has built a technology innovation platform covering the complete development chain from concept design to system integration—encompassing mechanical, electrical, optical, computational, software, and medical engineering disciplines.

As of March 2025, Agile Medical Technology has filed over 230 domestic and international patent applications covering core technology areas including surgical robot system design, control algorithms, and surgical instruments.

Core Products

AGIBOT Endoscopic Surgical Robot

The AGIBOT Endoscopic Surgical Robot is Agile Medical Technology’s flagship product, designed as a multi-arm platform for minimally invasive thoracic, abdominal, and pelvic procedures. The system received NMPA clearance on March 26, 2025 (Registration No. 国械注准20253010649), with initial approval for urological surgery indications.

The system comprises four main components:

• Surgeon Console: Features an immersive 3D ultra-HD visual display with a lightweight, multi-degree-of-freedom master control arm
• Patient Cart: A four-arm surgical platform with deployment guidance functionality
• Vision Platform: 3D fusion video image processor compatible with HD 3D laparoscopes and 4K 3D fluorescence laparoscopes
• Surgical Instruments: 11 types of reusable multi-degree-of-freedom robotic instruments

Clinical trials conducted between December 2023 and December 2024 included over 130 procedures across urology, hepatobiliary surgery, gastrointestinal surgery, colorectal surgery, gynecology, and thoracic surgery.

Technology & Innovation

Founded to advance minimally invasive surgery through domestic full-stack development, Agile Medical Technology builds visual, control, and instrument technologies for its AGIBOT surgical robot platform.

Agile Medical Technology has developed full-stack capabilities in surgical robotics, with independent R&D across multiple technical domains:

• Visual System: Supports third-party image source integration including ultrasound, CT, and endoscopic imaging
• Control Architecture: Dual-motor driven tiller mechanism for single-handed operation and flexible deployment
• Instrument Design: Multi-directional versatile deployment with precision instrument articulation

The company’s technology platform enables full system development from bottom-layer technology through system integration, maintaining control over core components and algorithms.

Market Presence

Following NMPA approval in March 2025, Agile Medical Technology has opened a user trial experience platform at its Suzhou headquarters. The platform, supported by a training team of engineers and clinical specialists, allows surgeons to evaluate the AGIBOT system’s capabilities before procurement decisions.

The company is targeting applications across multiple surgical departments including urology, general surgery (hepatobiliary, gastrointestinal, colorectal), gynecology, and thoracic surgery.

Key Milestones

• 2020-09: Company founded in Suzhou
• 2022-06: Completed first animal experiment with AGIBOT system
• 2023-04: Closed angel funding round
• 2023-09: AGIBOT passed type testing certification
• 2023-12: Closed Pre-A funding; achieved first-in-human urological procedure at Nanjing Drum Tower Hospital
• 2024-03: Completed urology registration trial enrollment
• 2024-06: Expanded to multi-department clinical application (hepatobiliary, gastrointestinal, thoracic surgery)
• 2024-07: Closed Series A funding
• 2024-08: Reached 100th clinical procedure milestone at PLA General Hospital
• 2024-10: Received Jiangsu Provincial Medical Products Administration clearance
• 2024-12: Completed multi-specialty registration trial enrollment
• 2025-03: AGIBOT received NMPA clearance; achieved ISO 13485:2016 certification from TÜV SÜD

Frequently Asked Questions

What is the AGIBOT surgical robot used for?

The AGIBOT Endoscopic Surgical Robot is designed for minimally invasive procedures in thoracic, abdominal, and pelvic cavities. It has been clinically validated across urology, hepatobiliary surgery, gastrointestinal surgery, colorectal surgery, gynecology, and thoracic surgery, with initial NMPA approval granted for urological indications.

Is Agile Medical Technology a publicly traded company?

No, Agile Medical Technology is a privately held company as of early 2026. The company has completed multiple funding rounds including angel, Pre-A, and Series A financing, with investors including Oriza Holdings and Qianji Capital.

How does AGIBOT compare to other Chinese surgical robots?

AGIBOT represents one of several domestically developed four-arm laparoscopic surgical robot platforms in China. The system completed over 130 clinical procedures during registration trials and received NMPA approval in March 2025. The company emphasizes full-stack independent R&D capabilities across mechanical, electrical, optical, and software domains.